{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:26:46Z","timestamp":1789946806822,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.neuropharm.2007.02.004","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T06:54:53Z","timestamp":1173164093000},"page":"1509-1520","source":"Crossref","is-referenced-by-count":41,"title":["Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity"],"prefix":"10.1016","volume":"52","author":[{"given":"Marc","family":"Morissette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Al Sweidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank S.","family":"Menniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres D.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2007.02.004_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrn846","article-title":"Oestrogen as a neuroprotective hormone","volume":"3","author":"Behl","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/mds.1170","article-title":"Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study","volume":"16","author":"Benedetti","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/me.2004-0486","article-title":"Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes","volume":"19","author":"Bjornstrom","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/exnr.1999.7259","article-title":"Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices","volume":"161","author":"Bywood","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5","article-title":"Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice","volume":"37","author":"Callier","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archneur.61.6.886","article-title":"Postmenopausal estrogen use affects risk for Parkinson disease","volume":"61","author":"Currie","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib8","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1124\/mol.105.018671","article-title":"Implication of the phosphatidylinositol-3 kinase\/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"69","author":"D'Astous","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib9","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.neuropharm.2004.08.020","article-title":"Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist","volume":"47","author":"D'Astous","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/syn.10145","article-title":"Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice","volume":"47","author":"D'Astous","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/REVNEURO.1994.5.1.27","article-title":"Modulation of brain dopamine transmission by sex steroids","volume":"5","author":"Di Paolo","year":"1994","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib12","series-title":"Recent Advances in Neurodegenerative Disorders","first-page":"149","article-title":"Estrogen as a modulator of striatal dopaminergic neurotoxicity","author":"Dluzen","year":"1998"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1007117424491","article-title":"Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system","volume":"29","author":"Dluzen","year":"2000","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0892-0362(96)00086-4","article-title":"Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57\/B1 mice","volume":"18","author":"Dluzen","year":"1996","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib15","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1210\/en.2005-1177","article-title":"Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death","volume":"147","author":"Dubal","year":"2006","journal-title":"Endocrinology"},{"issue":"Spec. No. 2","key":"10.1016\/j.neuropharm.2007.02.004_bib16","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/hmg\/ddi308","article-title":"Molecular pathogenesis of Parkinson's disease","volume":"14","author":"Gandhi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/320134a0","article-title":"Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A","volume":"320","author":"Green","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2826.2005.01337.x","article-title":"Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"17","author":"Jourdain","year":"2005","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/en.138.3.863","article-title":"Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta","volume":"138","author":"Kuiper","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib20","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","article-title":"Cloning of a novel receptor expressed in rat prostate and ovary","volume":"93","author":"Kuiper","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(99)00815-0","article-title":"Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum","volume":"276","author":"Kuppers","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2826.2005.01380.x","article-title":"Influence of oestrogenic compounds on\u00a0monoamine transporters in rat striatum","volume":"18","author":"Le Saux","year":"2006","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuropharm.2005.10.004","article-title":"ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens","volume":"50","author":"Le Saux","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib24","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1523\/JNEUROSCI.1443-06.2006","article-title":"Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1\/2 in the same population of cortical neurons: a unified mechanism of estrogen action","volume":"26","author":"Mannella","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2005.10.047","article-title":"Alternative estrogen receptors homologous to classical receptor alpha in murine neural tissues","volume":"395","author":"Marin","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.neuroscience.2005.10.019","article-title":"Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia","volume":"138","author":"Mhyre","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.1998.tb08230.x","article-title":"The impact of gender and estrogen on striatal dopaminergic neurotoxicity","volume":"844","author":"Miller","year":"1998","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib28","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/en.2002-221069","article-title":"Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha","volume":"144","author":"Mitra","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib29","first-page":"297","article-title":"Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr. Drug Targets CNS Neurol","volume":"3","author":"Nilsen","year":"2004","journal-title":"Disord."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2202-7-74","article-title":"Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function","volume":"7","author":"Nilsen","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib31","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1073\/pnas.0438041100","article-title":"Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression","volume":"100","author":"Nilsen","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib32","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1210\/me.11.10.1486","article-title":"Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha","volume":"11","author":"Pettersson","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib33","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.62.11.2010","article-title":"Risk of Parkinson disease in women: effect of reproductive characteristics","volume":"62","author":"Ragonese","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000070277","article-title":"Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice","volume":"77","author":"Ramirez","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1212\/WNL.52.7.1417","article-title":"The effect of estrogen replacement on early Parkinson's disease","volume":"52","author":"Saunders-Pullman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib36","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.expneurol.2004.08.009","article-title":"Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta)","volume":"190","author":"Shughrue","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/14737175.6.3.407","article-title":"Gender disparities in Parkinson's disease","volume":"6","author":"Shulman","year":"2006","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.7326\/0003-4819-138-8-200304150-00013","article-title":"Update on Parkinson disease","volume":"138","author":"Siderowf","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/153537020623100505","article-title":"Novel mechanisms for estrogen-induced neuroprotection","volume":"231","author":"Singh","year":"2006","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib41","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1073\/pnas.041617498","article-title":"Morphological abnormalities in the brains of estrogen receptor beta knock out mice","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/er.2004-0014","article-title":"Are estrogens protective or risk factors in brain injury and neurodegeneration? Reevaluation after the Women's health initiative","volume":"26","author":"Wise","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson's disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2007.02.004_bib44","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1073\/pnas.0306948101","article-title":"Mitochondrial localization of estrogen receptor beta","volume":"101","author":"Yang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.brainresrev.2005.01.009","article-title":"Selective estrogen receptor\u00a0modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs","volume":"49","author":"Zhao","year":"2005","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2007.02.004_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(99)00012-6","article-title":"Rapid inhibition of rat brain mitochondrial proton F0F1-ATPase activity by estrogens: comparison with Na+,K+-ATPase of porcine cortex","volume":"368","author":"Zheng","year":"1999","journal-title":"Eur. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390807000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T03:24:52Z","timestamp":1556162692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390807000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0028390807000548"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2007.02.004","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}